Medicines appraisal cards

Medicines appraisal cards have been developed for the Guidelines audience to announce new recommendations from the National Institute for Health and Care Excellence (NICE), the Scottish Medicines Consortium (SMC), and the All Wales Medicines Strategy Group (AWMSG). Items may contain pharmaceutical promotional information.

Klisyri (tirbanibulin) SMC card - digital

Tirbanibulin 10mg/g ointment (Klisyri®▼) SMC2395

Commissioned by Almirall Ltd

The production of this Guidelines card has been commissioned by Almirall Ltd.
View prescribing and adverse event reporting information
IE-KLI-2100016 December 2021

Daiichi Sankyo logo

Bempedoic acid (Nilemdo®▼) and Bempedoic acid / ezetimibe (Nustendi®▼) SMC card

Commissioned and funded by Daiichi Sankyo

The production of this Guidelines card has been commissioned and funded by Daiichi Sankyo UK. This content is for healthcare professionals only.
View Bempedoic acid (Nilemdo®) & Bempedoic acid and ezetimibe (Nustendi®) prescribing and adverse event reporting information
BEM/21/0777 December 2021

Jardiance SMC guidance card index image

Empagliflozin (Jardiance®) 10mg film-coated tablets SMC2396

Promotional material from the Boehringer Ingelheim and Lilly Alliance

The production of this Guidelines  summary card has been commissioned by the Boehringer Ingelheim and Lilly Alliance.
View Jardiance® (empagliflozin) prescribing and adverse event reporting information for Great Britain and Northern Ireland.
PC-GB-105816 October 2021

20201002 Rizmoic TA card V5 image

NICE Technology Appraisal 651: Naldemedine ▼ for treating opioid‑induced constipation

Commissioned by Sandoz Limited

The production and printing of this Guidelines summary card has been commissioned by Sandoz Ltd. Information intended for UK healthcare professionals only.
View prescribing information

UK/P/RZM/20-0016c October 2020